Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.

Väätäinen U, Lohmander LS, Thonar E, Hongisto T, Agren U, Rönkkö S, Jaroma H, Kosma VM, Tammi M, Kiviranta I.

Osteoarthritis Cartilage. 1998 Mar;6(2):115-24.

2.

Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs.

Panula HE, Lohmander LS, Rönkkö S, Agren U, Helminen HJ, Kiviranta I.

Acta Orthop Scand. 1998 Apr;69(2):152-8.

PMID:
9602773
3.

Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.

Arthritis Rheum. 2003 Nov;48(11):3085-95.

4.

Cartilage metabolism in the injured and uninjured knee of the same patient.

Dahlberg L, Roos H, Saxne T, Heinegård D, Lark MW, Hoerrner LA, Lohmander LS.

Ann Rheum Dis. 1994 Dec;53(12):823-7.

5.
6.

Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.

Lohmander LS, Dahlberg L, Eyre D, Lark M, Thonar EJ, Ryd L.

Osteoarthritis Cartilage. 1998 Sep;6(5):351-61.

7.

Effects of moving training on histology and biomarkers levels of articular cartilage.

Qi C, Changlin H.

J Surg Res. 2006 Oct;135(2):352-63. Epub 2006 Aug 14.

PMID:
16904690
8.
12.

New potential markers for cartilage degradation of the knee joint.

Schmidt-Rohlfing B, Gavenis K, Kippels M, Schneider U.

Scand J Rheumatol. 2002;31(3):151-7.

PMID:
12195629
13.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.

Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.

J Orofac Pain. 2000 Winter;14(1):20-30.

PMID:
11203734
15.

Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation?

Bobacz K, Maier R, Fialka C, Ekhart H, Woloszczuk W, Geyer G, Erlacher L, Smolen J, Graninger WB.

Osteoarthritis Cartilage. 2003 Sep;11(9):665-72.

16.

Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs.

Haapala J, Arokoski JP, Rönkkö S, Agren U, Kosma VM, Lohmander LS, Tammi M, Helminen HJ, Kiviranta I.

Ann Rheum Dis. 2001 Jan;60(1):55-60.

17.

Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.

Céleste C, Ionescu M, Robin Poole A, Laverty S.

J Orthop Res. 2005 May;23(3):602-10. Epub 2004 Dec 21.

18.

Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.

Ratcliffe A, Beauvais PJ, Saed-Nejad F.

J Orthop Res. 1994 Jul;12(4):464-73.

PMID:
7520485
19.

Cartilage markers in synovial fluid in symptomatic knee osteoarthritis.

Petersson IF, Sandqvist L, Svensson B, Saxne T.

Ann Rheum Dis. 1997 Jan;56(1):64-7.

20.

Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.

Roos H, Dahlberg L, Hoerrner LA, Lark MW, Thonar EJ, Shinmei M, Lindqvist U, Lohmander LS.

Osteoarthritis Cartilage. 1995 Mar;3(1):7-14.

Supplemental Content

Support Center